Nidhi Gupta

Bio: Nidhi Gupta is an academic researcher from Central University of Rajasthan. The author has contributed to research in topics: Helicobacter pylori & Outpatient clinic. The author has an hindex of 8, co-authored 29 publications receiving 227 citations. Previous affiliations of Nidhi Gupta include Jawaharlal Nehru University & University of Delhi.

Biologically Relevant Macrocyclic Complexes of Copper Spectral, Magnetic, Thermal and Antibacterial Approach

Abstract: Copper(II) macrocyclic complexes have been synthesized with five novel ligands: L1-1,7,10,16-tetraaza-2,6,11,15-tetraone-4,13-dithiacycloocta-decane, L2-1,7,11,17-tetraaza-2,6,12,16-tetraone-4,14-dithia-cyclocosane, L3-1,7,10, 13,19,22-hexaaza-2,6,14,18-tetraone-4,16-dithiacyclo-tetracosane, L4-1,7,14,20,tetraaza-2,6,15,19-tetraone-4,17,di- thiatricyclo [22, 4, O21,26, O8,13] hexacosa-8,10,12,21,23,25-hexene, L5- 1,7,13,19,25,26-hexaaza-2,6,14,18 tetraone-4,16 dithia tricyclo [23, 3, 1, I8,12] hexacosa [8(26), 10, 12, 20(25), 22, 24] hexane and characterized by elemental analysis, molar conductance, magnetic susceptibility, i.r, u.v.–vis, EPR spectral studies, thermal studies and electrochemical properties. The molar conductance measurements of the complexes in DMSO correspond to 1:2 electrolytes. g-Values are calculated for all of the complexes in the polycrystalline form as well as in DMSO solution. On the basis of i.r, electronic and EPR spectral studies a square planar geometry has been assigned to these complexes. Cyclic voltammograms for all the complexes are similar to quasi-reversible redox processes CuIICuII⇆CuIICuI⇆CuICuI. The complexes were also evaluated against the growth of bacteria (S. fecalis and E.coli) in vitro.

Synthesis and EPR Spectral Studies of Mono- and Binuclear Cobalt(II) and Nickel(II) Complexes with New 20‐Membered Dithiatetraazamacrocyclic [N4S2] Ligand

Abstract: A new ligand, 6,10,16,20‐tetraketo‐8,18‐dithia‐1,5,11,15‐tetraazacycloeicosane [N4S2] (L), and its complexes with cobalt(II) and nickel(II), have been synthesized and characterized by elemental analyses, molar conductance, magnetic susceptibility measurements, EPR and electronic spectral studies. The complexes were found to have the general composition [ML]X2 and [M2LX2]X2 for mono and binuclear complexes (M = Co, Ni; X = Cl, NO3, and SCN; and L = macrocyclic ligand). The mononuclear complexes of Co(II) and Ni(II) were found to have six‐coordinated octahedral geometry. However, the binuclear complexes of Co(II) and Ni(II) are square‐planar.

Regulation of Plasmodium falciparum Origin Recognition Complex subunit 1 (PfORC1) function through phosphorylation mediated by CDK‐like kinase PK5

Abstract: Plasmodium falciparum Origin Recognition Complex subunit 1 (PfORC1) has been implicated in DNA replication and var gene regulation. While the C-terminus is involved in DNA replication, the specific role of N-terminus has been suggested in var gene regulation in a Sir2-dependent manner. PfORC1 is localized at the nuclear periphery, where the clustering of chromosomal ends at the early stage of parasite development may be crucial for the regulation of subtelomeric var gene expression. Upon disassembly of telomeric clusters at later stages of parasite development, ORC1 is distributed in the nucleus and parasite cytoplasm where it may be required for its other cellular functions including DNA replication. The level of ORC1 decreases dramatically at the late schizont stage. The mechanisms that mediate regulation of PfORC1 function are largely unknown. Here we show, by the use of recombinant proteins and of transgenic parasites expressing wild type or mutant forms of ORC1, that phosphorylation of the PfORC1-N terminal domain by the cyclin-dependent kinase (CDK) PfPK5 abolishes DNA-binding activity and leads to changes in subcellular localization and proteasome-mediated degradation of the protein in schizonts. These results reveal that PfORC1 phosphorylation by a CDK is central to the regulation of important biological functions like DNA replication and var gene silencing.

Coronavirus Disease 2019–COVID-19

Abstract: SUMMARYIn recent decades, several new diseases have emerged in different geographical areas, with pathogens including Ebola virus, Zika virus, Nipah virus, and coronaviruses (CoVs). Recently, a new type of viral infection emerged in Wuhan City, China, and initial genomic sequencing data of this virus do not match with previously sequenced CoVs, suggesting a novel CoV strain (2019-nCoV), which has now been termed severe acute respiratory syndrome CoV-2 (SARS-CoV-2). Although coronavirus disease 2019 (COVID-19) is suspected to originate from an animal host (zoonotic origin) followed by human-to-human transmission, the possibility of other routes should not be ruled out. Compared to diseases caused by previously known human CoVs, COVID-19 shows less severe pathogenesis but higher transmission competence, as is evident from the continuously increasing number of confirmed cases globally. Compared to other emerging viruses, such as Ebola virus, avian H7N9, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 has shown relatively low pathogenicity and moderate transmissibility. Codon usage studies suggest that this novel virus has been transferred from an animal source, such as bats. Early diagnosis by real-time PCR and next-generation sequencing has facilitated the identification of the pathogen at an early stage. Since no antiviral drug or vaccine exists to treat or prevent SARS-CoV-2, potential therapeutic strategies that are currently being evaluated predominantly stem from previous experience with treating SARS-CoV, MERS-CoV, and other emerging viral diseases. In this review, we address epidemiological, diagnostic, clinical, and therapeutic aspects, including perspectives of vaccines and preventive measures that have already been globally recommended to counter this pandemic virus.

Synthesis and characterization of complexes of Co(II), Ni(II), Cu(II), Zn(II), and Cd(II) with macrocycle 3,4,11,12-tetraoxo-1,2,5,6,9,10,13,14-octaaza-cyclohexadeca-6,8,14,16-tetraene and their biological screening

Abstract: A new series of complexes is synthesized by template condensation of glyoxal and oxalyldihydrazide in methanolic medium in the presence of divalent cobalt, nickel, copper, zinc and cadmium salts forming complexes of the type: [M(C8H8N8O4)X2] where M = Co(II), Ni(II), Cu(II), Zn(II), Cd(II) and X = Cl−1, Br−1, NO 3 −1 , OAc−1. The complexes have been characterized with the help of elemental analyses, conductance measurements, magnetic susceptibility measurements, electronic, n.m.r., infrared and far infrared spectral studies. On the basis of these studies, a six coordinate octahedral geometry for these complexes has been proposed. The biological activities of the metal complexes have been tested in vitro against a number of pathogenic bacteria to assess their inhibiting potential. Most of the compounds have been found to exhibit remarkable antibacterial activities.